Cevidoplenib

N/A

Report date: 2024/03/22 09:29:39
NME

Base Information

Drug NameCevidoplenib
Drug Alias NameMesylate salt of SKI-O-592SKI-O-703SKI-O-592 (free base)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSpleen tyrosine kinase inhibitors
TargetsSpleen tyrosine kinase
Therapy Area/IndicationsPurpura, Thrombocytopenic, IdiopathicArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesUkraine +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOscotec Inc
China Registration ClassN/A

Develop Information

Active CompaniesOscotec Inc
Inactive CompaniesN/A
Active IndicationsPurpura, Thrombocytopenic, Idiopathic
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A